Related Experiment Video

Updated: Jul 10, 2026

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

Successful non-myeloablative allogeneic HLA-identical stem cell transplantation for CD4/CD56 positive acute leukemia

Ramzi Ben Amor, Yosr Hicheri, Cécile Pautas

    Transplantation
    |November 9, 2007
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
    09:01

    Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

    Published on: March 26, 2018

    Related Experiment Videos

    Last Updated: Jul 10, 2026

    Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
    11:55

    Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

    Published on: March 14, 2011

    Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
    09:01

    Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

    Published on: March 26, 2018

    Related Concept Videos

    Bone Marrow Sampling and Transplants01:22

    Bone Marrow Sampling and Transplants

    Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
    The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
    Stem Cell Therapy for Tissue Regeneration01:21

    Stem Cell Therapy for Tissue Regeneration

    Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
    Types of Stem Cells used in Stem Cell Therapy
    The two main cell types that...

    Articles linked to this work by shared authors, journal, and citation graph.

    Ivosidenib monotherapy in IDH1 mutated myelodysplastic neoplasm/syndrome.

    Leukemia·2026

    Fecal microbiota transplantation in the treatment of acute graft-versus-host disease: A retrospective study performed by the Complications Working Party and Pediatric Diseases Working Party of the EBMT.

    Bone marrow transplantation·2026

    Non-culture based diagnostic tests for detection of bacterial infections in hematology patients with febrile neutropenia: A review by the European Conference on Infections in Leukemia (ECIL-10).

    Current research in translational medicine·2026

    Prognostic impact of FLT3-ITD microclones in young adults with acute myeloid leukemia treated with intensive chemotherapy.

    Blood·2026

    Blinatumomab consolidation for high-risk Ph- B-cell acute lymphoblastic leukemia: the GRAALL-2014/B-QUEST study.

    Blood·2026

    Comprehensive mutational profiling and clinical outcome of adult acute myeloid leukemia patients with NUP98 rearrangement.

    Leukemia·2026

    Two Genomes, one Outcome: Stratifying Donor and Recipient Polygenic Risk Score to Improve Kidney Allograft Longevity.

    Transplantation·2026

    Study on the Antirejection Effects of the Dual ICOS and CD28 Antagonist Acazicolcept (ALPN-101) in Mouse Skin and Heart Transplantation Models.

    Transplantation·2026

    International Travel for Organ Transplantation: 2024 Multinational Survey of Routes, Organs, and Donor Types.

    Transplantation·2026

    HPV-associated Anal Dysplasia in Solid Organ Transplant Recipients: A Transplant-specific Model of Mucosal Immune Dysfunction.

    Transplantation·2026

    Cancer Risk in Kidney Transplant Recipients on Belatacept Versus Calcineurin Inhibitors: A Systematic Review and Meta-Analysis.

    Transplantation·2026

    Neurocognitive Recovery After Liver Transplantation Is Driven by Metabolite-mediated Reactivation of Cortical Networks.

    Transplantation·2026

    Sustained LDL-C target attainment and recurrent ischemic cerebrovascular events after ischemic stroke: effect modification by large-artery disease.

    Frontiers in neurology·2026

    c.1681-7 G>A Variant in the Factor XII Gene in a Family Diagnosed with HAE-FXII Does Not Affect Splice Site.

    Pediatric allergy, immunology, and pulmonology·2026

    Habenula as a Marker of Thalamic Asymmetrical Skew and a Landmark for the Vim-Vc Boundary in MRgFUS Thalamotomy.

    Stereotactic and functional neurosurgery·2026

    Retrograde Collateral Crossing Through Riolan's Arcade With Femoral Antegrade Reconstruction After Traction During Upper-Extremity Externalization.

    JACC. Case reports·2026

    Central nervous system management remains an evidence gap in first-line tagraxofusp therapy for blastic plasmacytoid dendritic cell neoplasm. Comment on: "First-line tagraxofusp leads to durable responses and prolonged survival in adults with blastic plasmacytoid dendritic cell neoplasm regardless of fitness level".

    Haematologica·2026

    Fibrinogen and leukemic-cell trafficking: possible implications for hyperleukocytosis and differentiation syndrome. Comment on: "Fibrinogen promotes acute myelogenous leukemia progression via miR-486/GPR153 axis".

    Haematologica·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us